HIV/AIDS News and Research

RSS

Acquired immune deficiency syndrome or acquired immunodeficiency syndrome (AIDS) is a disease of the human immune system caused by the human immunodeficiency virus (HIV).

Journalists meet to discuss different aspects of biotechnology and its impact on society

More than 90 journalists from all over the world meet in Heidelberg, today, for the 4th Alumni Conference of the International Journalists’ Programmes (IJP). In keynote-speeches, panel discussions and excursions participants will discover different aspects of biotechnology and its impact on society.

8 Oct 2009

Kaiser Permanente launches osteoporosis prevention campaign

Encouraging everyone to “Embrace Your Inner Strength,” Kaiser Permanente has launched a campaign throughout Southern California aimed at getting teenagers, seniors and everyone in between to get serious about building up their skeletons and preventing osteoporosis.

8 Oct 2009

Paratek Pharmaceuticals and Novartis to collaborate in PTK 0796 broad-spectrum antibiotic development

Paratek Pharmaceuticals, Inc. announced today that it has entered into an exclusive worldwide collaborative development, manufacturing and commercialization license agreement with Novartis for Paratek's lead broad-spectrum antibiotic, PTK 0796, a first-in-class aminomethylcycline (AMC) in Phase 3 clinical trials.

8 Oct 2009

New research report outlines growth prospects of Biomagnetics Diagnostics

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, and malaria detection, today announced the Company is the subject of a new research report issued by Emerging Growth Research, LLP.

8 Oct 2009

UNFPA provides humanitarian assistance to disaster-affected countries

Following the recent series of natural disasters in Asia and the Pacific, UNFPA, the United Nations Population Fund, is providing humanitarian assistance in affected countries throughout the region.

8 Oct 2009

HTDS' Hepatitis A vaccine receives GMP Certificate from the Russian FDA

HTDS www.htdsmedical.com (HTDS) - The issuer's China based operating subsidiary Mellow Hope www.mellowhope.com is pleased to announce that its Hepatitis A Live Attenuated Vaccine (Brand name: Mevac-A) associate operation plant has obtained the GMP Certificate (Good Manufacturing Practice See Description http://en.wikipedia.org/wiki/Good_manufacturing_practice) from the Russian FDA. http://www.who.int/hiv/HIVCP_RUS.pdf

8 Oct 2009

Hutchinson Center scientists awarded $16.7M to develop progenitor and stem cell tools

The National Heart, Lung and Blood Institute has awarded a total of $16.7 million to Irwin Bernstein, M.D., and Beverly Torok-Storb, Ph.D., both members of the Clinical Research Division at Fred Hutchinson Cancer Research Center. The Hutchinson Center grants represent part of a $170 million effort involving 18 teams of research scientists dedicated to developing stem- and progenitor-cell tools and therapies.

8 Oct 2009

Sangamo declares pricing of common stock; grants option to purchase additional 450,000 shares

Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced the pricing of a public offering of 3,000,000 shares of its common stock. The offering is expected to close on or about October 13, 2009, subject to the satisfaction of customary closing conditions.

8 Oct 2009

Needlestick injuries in home care nursing can also affect patients

Patients continue to enter home healthcare ''sicker and quicker," often with complex health problems that may require extensive nursing care. This increases the risk of needlestick injuries in home healthcare nurses.

8 Oct 2009

More than 2m infants, women die from childbirth annually, study says

Each year, more than 2 million infants and women around the world die from childbirth-related complications, according to a study released Tuesday at the International Federation of Gynecology and Obstetrics world congress in Cape Town, South Africa, the Associated Press reports.

8 Oct 2009

Also in Global Health News: Carter promotes malaria eradication; India to educate tribal populations about HIV/AIDS; WFP feels impact of global recession

Former President Jimmy Carter is traveling to Haiti and the Dominican Republic in hopes of encouraging the country "leaders to forge a pact to rid the island of Hispaniola of malaria," the Associated Press/Los Angeles Times reports.

8 Oct 2009

Peregrine Pharmaceuticals establishes a new Anti-Viral Research Group

Peregrine Pharmaceuticals, Inc. today announced that it has established a new Anti-Viral Research Group in its R&D organization.

7 Oct 2009

Nutra Pharma to launch prescription analgesic for severe chronic pain treatment

Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today its intent to launch a prescription analgesic, Nyloxin Rx, for the treatment of severe (Stage 3) chronic pain.

7 Oct 2009

HHS and PEPFAR approve the 100th HIV/AIDS antiretroviral drug

The U.S. Department of Health and Human Services (HHS) today marked today marked the recent approval of the 100th antiretroviral drug in association with the President's Emergency Plan for AIDS Relief (PEPFAR), aimed at the prevention, treatment, and care of people infected with and affected by HIV/AIDS worldwide.

7 Oct 2009

Reuters examines health effects of climate change in Africa

Reuters examines how floods, droughts and rising temperatures, thought to be caused by climate change, are compromising African farm lands and leading to health problems for already vulnerable populations - a topic discussed at the "first pan-African climate hearings."

7 Oct 2009

$16 million federal stimulus funds establish Seattle as national hub for cancer research

Researchers at Fred Hutchinson Cancer Research Center, Group Health Research Institute and the University of Washington schools of Public Health and Pharmacy have been selected to lead four projects backed by approximately $16 million in federal stimulus funding for comparative-effectiveness research in cancer.

7 Oct 2009

Also in Global Health News: U.S. aid to Somalia; Nigerian health workers strike; male circumcision in Swaziland; PEPFAR in Uganda

The U.S. State and Treasury departments together with USAID have reached an agreement that will allow several aid agencies in Somalia to receive humanitarian grants upon meeting several conditions, "unlock[ing] millions of dollars in relief resources that had been on hold due to US anti-terrorism rules," IRIN reports.

7 Oct 2009

PDS Biotechnology's Versamune-based immunotherapy drug demonstrates safety in preclinical studies

PDS Biotechnology Corporation today announced that the company has completed GLP toxicology studies of its lead HPV-cancer product. The studies, which included pharmacokinetic (PK) and adsorption, bio-distribution and excretion (ADE) studies in addition to the evaluation of toxicity, all demonstrated a very safe profile of the drug and PDS Biotech's platform Versamune((TM)) technology.

6 Oct 2009

The latest medication to treat schizophrenia "ABILIFY" launched in Canada

A new treatment option for Canadians with schizophrenia, ABILIFY(TM) (aripiprazole), is now available in Canada. For those living with this lifelong disease who may be struggling with a treatment that doesn't work for them or with side effects that are difficult to tolerate, ABILIFY offers efficacy and good safety and tolerability with limited impact on weight, blood sugar and lipids - significant clinical benefits that may help patients stay on treatment longer.

6 Oct 2009

HIV prevalence high among African Americans

HIV prevalence among African Americans is ten times greater than the prevalence among whites. This racial disparity in HIV prevalence has persisted in the face of both governmental and private actions, involving many billions of dollars, to combat HIV.

6 Oct 2009

HIV/AIDS News and Research

Further Reading

Journalists meet to discuss different aspects of biotechnology and its impact on society

Kaiser Permanente launches osteoporosis prevention campaign

Paratek Pharmaceuticals and Novartis to collaborate in PTK 0796 broad-spectrum antibiotic development

New research report outlines growth prospects of Biomagnetics Diagnostics

UNFPA provides humanitarian assistance to disaster-affected countries

HTDS' Hepatitis A vaccine receives GMP Certificate from the Russian FDA

Hutchinson Center scientists awarded $16.7M to develop progenitor and stem cell tools

Sangamo declares pricing of common stock; grants option to purchase additional 450,000 shares

Needlestick injuries in home care nursing can also affect patients

More than 2m infants, women die from childbirth annually, study says

Also in Global Health News: Carter promotes malaria eradication; India to educate tribal populations about HIV/AIDS; WFP feels impact of global recession

Peregrine Pharmaceuticals establishes a new Anti-Viral Research Group

Nutra Pharma to launch prescription analgesic for severe chronic pain treatment

HHS and PEPFAR approve the 100th HIV/AIDS antiretroviral drug

Reuters examines health effects of climate change in Africa

$16 million federal stimulus funds establish Seattle as national hub for cancer research

Also in Global Health News: U.S. aid to Somalia; Nigerian health workers strike; male circumcision in Swaziland; PEPFAR in Uganda

PDS Biotechnology's Versamune-based immunotherapy drug demonstrates safety in preclinical studies

The latest medication to treat schizophrenia "ABILIFY" launched in Canada

HIV prevalence high among African Americans

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News